A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity.


Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
30 Jan 2021
Historique:
received: 13 05 2020
revised: 24 09 2020
accepted: 31 10 2020
pubmed: 21 11 2020
medline: 22 6 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

Obesity has reached an epidemic level worldwide, and bariatric surgery (BS) has been proven to be the most efficient therapy to reduce severe obesity-related comorbidities. Given that the gut microbiota plays a causal role in obesity development and that surgery may alter the gut environment, investigating the impact of BS on the microbiota in the context of severe obesity is important. Although, alterations at the level of total gut bacteria, total gene content and total metabolite content have started to be disentangled, a clear deficit exists regarding the analysis of the active fraction of the microbiota, which is the fraction that is most reactive to the BS. Here, active gut microbiota and associated metabolic functions were evaluated using shotgun proteomics and metabolomics in 40 severely obese volunteers. Samples from each volunteer were obtained under basal conditions, after a short high protein and calorie-restricted diet, and 1 and 3 months after BS, including laparoscopic surgery through Roux-en-Y Gastric Bypass or Sleeve Gastrectomy. The results revealed for the first time the most active microbes and metabolic flux distribution pre- and post-surgery and deciphered main differences in the way sugars and short-fatty acids are metabolized, demonstrating that less energy-generating and anaerobic metabolism and detoxification mechanisms are promoted post-surgery. A comparison with non-obese proteome data further signified different ways to metabolize sugars and produce short chain fatty acids and deficiencies in proteins involved in iron transport and metabolism in severely obese individuals compared to lean individuals.

Identifiants

pubmed: 33217711
pii: S0731-7085(20)31633-2
doi: 10.1016/j.jpba.2020.113747
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113747

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Sergio Sanchez-Carrillo (S)

Institute of Catalysis, Consejo Superior de Investigaciones Científicas, 28049, Madrid, Spain.

Sergio Ciordia (S)

Unidad de Proteómica, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), 28049, Madrid, Spain.

David Rojo (D)

Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain.

Elisa Zubeldia-Varela (E)

Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain; Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain.

Celia Méndez-García (C)

Institute of Catalysis, Consejo Superior de Investigaciones Científicas, 28049, Madrid, Spain.

Mónica Martínez-Martínez (M)

Institute of Catalysis, Consejo Superior de Investigaciones Científicas, 28049, Madrid, Spain.

Coral Barbas (C)

Centre for Metabolomics and Bioanalysis (CEMBIO), Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain.

Susana Ruiz-Ruiz (S)

Unidad Mixta de Investigación en Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020, València, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain; Instituto de Biología Integrativa de Sistemas, Universitat de València and Consejo Superior de Investigaciones Científicas (CSIC), 46980, València, Spain.

Andrés Moya (A)

Unidad Mixta de Investigación en Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020, València, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain; Instituto de Biología Integrativa de Sistemas, Universitat de València and Consejo Superior de Investigaciones Científicas (CSIC), 46980, València, Spain.

María Garriga (M)

Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal & IRyCIS, 28034, Madrid, Spain.

Nuria Salazar (N)

Department of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300, Villaviciosa, Asturias, Spain; Diet, Human Microbiota and Health Group, Institute of Health Research of the Principality of Asturias (ISPA), 33011, Oviedo, Spain.

José I Botella-Carretero (JI)

Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal & IRyCIS, 28034, Madrid, Spain; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 28029, Madrid, Spain.

Belén Vega-Piñero (B)

Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal & IRyCIS, 28034, Madrid, Spain.

Clara G de Los Reyes-Gavilán (CG)

Department of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300, Villaviciosa, Asturias, Spain; Diet, Human Microbiota and Health Group, Institute of Health Research of the Principality of Asturias (ISPA), 33011, Oviedo, Spain.

Rosa Del Campo (R)

Servicio de Microbiología, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain. Electronic address: rosa.campo@salud.madrid.org.

Manuel Ferrer (M)

Institute of Catalysis, Consejo Superior de Investigaciones Científicas, 28049, Madrid, Spain. Electronic address: mferrer@icp.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH